247 related articles for article (PubMed ID: 35047554)
1. The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma.
Zhang S; Li X; Zhang X; Zhang S; Tang C; Kuang W
Front Mol Biosci; 2021; 8():781427. PubMed ID: 35047554
[No Abstract] [Full Text] [Related]
2. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
Li H; Li T; Zhang X
Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma.
Li X; Zhang S; Zhang S; Kuang W; Tang C
J Oncol; 2022; 2022():9917244. PubMed ID: 35342418
[TBL] [Abstract][Full Text] [Related]
4. A novel pyroptosis risk model composed of NLRP6 effectively predicts the prognosis of hepatocellular carcinoma patients.
Gao X; Wang WX; Zhang XL
Cancer Med; 2023 Jan; 12(1):808-823. PubMed ID: 35651286
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
6. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma.
Wang H; Zhang B; Shang Y; Chen F; Fan Y; Tan K
Aging (Albany NY); 2023 Feb; 15(5):1412-1444. PubMed ID: 36920176
[TBL] [Abstract][Full Text] [Related]
7. The Pyroptosis-Related Signature Composed of GSDMC Predicts Prognosis and Contributes to Growth and Metastasis of Hepatocellular Carcinoma.
Li M; Jiang Q; Liu X; Han L; Chen S; Xue R
Front Biosci (Landmark Ed); 2023 Oct; 28(10):235. PubMed ID: 37919059
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a pyroptosis-related gene signature in hepatocellular carcinoma based on RNA sequencing.
He J; Ran J; Li J; Chen D
Transl Cancer Res; 2022 Jun; 11(6):1510-1522. PubMed ID: 35836524
[TBL] [Abstract][Full Text] [Related]
9. A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma.
Lin D; Chen Z; Zeng Y; Ding Y; Zhao L; Xu Q; Yu F; Song X; Zhu X
BMC Med Genomics; 2023 Jan; 16(1):2. PubMed ID: 36611208
[TBL] [Abstract][Full Text] [Related]
10. A newly identified pyroptosis-related gene signature for predicting prognosis of patients with hepatocellular cancer.
Shen Q; Jiang Y; Hu X; Du Z
Transl Cancer Res; 2022 Sep; 11(9):3175-3186. PubMed ID: 36237236
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma.
Zheng S; Xie X; Guo X; Wu Y; Chen G; Chen X; Wang M; Xue T; Zhang B
Front Genet; 2021; 12():789296. PubMed ID: 34925465
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma.
Ding J; He X; Luo W; Zhou W; Chen R; Cao G; Chen B; Xiong M
Front Genet; 2022; 13():801419. PubMed ID: 35140750
[TBL] [Abstract][Full Text] [Related]
13. An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis.
Wang H; Wang N; Tang Z; Liu Q; Nie S; Tao W
Hereditas; 2023 Jul; 160(1):30. PubMed ID: 37464443
[TBL] [Abstract][Full Text] [Related]
14. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.
Liu ZK; Wu KF; Zhang RY; Kong LM; Shang RZ; Lv JJ; Li C; Lu M; Yong YL; Zhang C; Zheng NS; Li YH; Chen ZN; Bian H; Wei D
Front Oncol; 2022; 12():794034. PubMed ID: 35311105
[TBL] [Abstract][Full Text] [Related]
15. A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
Zhang B; Wang Z
Front Mol Biosci; 2022; 9():890215. PubMed ID: 36262473
[No Abstract] [Full Text] [Related]
16. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
[TBL] [Abstract][Full Text] [Related]
17. A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies.
Xu Y; Chen Y; Niu Z; Xing J; Yang Z; Yin X; Guo L; Zhang Q; Qiu H; Han Y
Front Med (Lausanne); 2022; 9():841568. PubMed ID: 35492358
[TBL] [Abstract][Full Text] [Related]
18. Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.
Chen X; Yang M; Wang L; Wang Y; Tu J; Zhou X; Yuan X
BMC Cancer; 2023 May; 23(1):411. PubMed ID: 37149620
[TBL] [Abstract][Full Text] [Related]
19. Identification of Pyroptosis Gene Signature Related Molecular Pattern, Clinical Implication, and Tumor Immunity in Hepatocellular Carcinoma`.
Li YT; Zeng XZ
Comb Chem High Throughput Screen; 2023; 26(7):1324-1336. PubMed ID: 36017840
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma.
Zhang Z; Xia F; Xu Z; Peng J; Kang F; Li J; Zhang W; Hong Q
Sci Rep; 2022 May; 12(1):8886. PubMed ID: 35614201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
